Haemostasis Flashcards

1
Q

why is haemostasis needed in blood?

A
  1. Coagulation following injury
  2. Prevention of extreme blood clotting (thrombosis)
  3. Fibrinolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the actions taken by the body to ‘halt’ the blood following trauma?

A
  • 3 intertwined processes
    1) Vasoconstriction
    2) primary haemostasis (unstable platelet plug)
    3) secondary haemostasis/coagulation (fibrin clot)
  • fibrin clot binds to platelet plug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why is it important to understand these mechanisms?

A
  • blood disorders
  • risks of thrombosis
  • treat thrombotic disorders
  • monitor drug involved in bleeding
  • control bleeding in general pop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the steps that happen in response to injury?

A

Vasoconstriction → primary haemostasis → secondary haemostasis → fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what two processes does primary haemostats involve?

A
  • platelet adhesion

- platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what process does secondary haemostasis involve?

A

-formation of a fibrin clot (coagulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what does fibrinolysis involve?

A

dissolution of the blood clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

where are platelets derived from?

A

myeloid stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the key features of platelets?

A
  • discoid
  • non-nucleated (classified as cell fragments)
  • granule-containing (alpha + dense granules)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe the process fo platelet adhesion (primary haemostasis part 1)

A

platelets stick to damaged endothelium following injury through one of two ways:

1) direct → glycoprotein-Ia (GPIa) receptor binding to collagen
2) indirect → GPIb + Von Willebrand factor binds to collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what does platelet adhesion cause?

A

1) activation
2) change in shape from disc → rounded with spicules (encourages interaction)
3) release action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what happens during the platelet release action?

A

after it is activated, releases contents of storage granules:

1) ADP
2) fibrinogen
3) von Willebrand factor
4) A2 thromboxane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the role of A2 thromboxane?

A
  • causes positive feedback in platelet recruitment + aggregation
  • vasoconstrictor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what happens during platelet aggregation?

A

A2 thromboxane + ADP → platelet activation → conformational change in receptors so fibrinogen can bind (ADP can expose a receptor which enables platelets to link together) → link platelets together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how is inappropriate platelet aggregation avoided?

A
  • prostacyclin (powerful vasodilator)

- active blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

give two examples of antiplatelet drugs

A

1) aspirin → reduced platelet aggregation

2) clopidogrel → block ADP receptor

17
Q

what is the role of Von Willebrand factor?

A
  • glycoprotein
    1) mediates the adhesion of platelets to sites of injury (indirect platelet adhesion)

2)promotes platelet-platelet aggregation

18
Q

when is secondary haemostasis (coagulation) needed?

A

in larger vessels, platelet plug not strong enough so fibrin needed to stabilise it

19
Q

where are clotting factors synthesised?

A

-liver (except VWF + VIII made in endothelial cells)

20
Q

what three steps are involved in the synthesis of clotting factors?

A

initiation → amplification → propagation

21
Q

give three examples of 3 artificial anticoagulants

A

1) Heparin → Incr. antithrombin
2) Warfarin → Interfere with carboxylation
3) DOACs → Inhibit either thrombin or factor Xa

22
Q

give three examples of 3 natural anticoagulants

A
  • ensures coagulation is confined to site of injury
    1. antithrombin → inhibits thrombin + factor Xa
    2. protein C → becomes APC
    3. protein S → acts as a co-factor with activated protein C (APC)
23
Q

what is the primary fibrinolytic enzyme?

A

plasmin (circulates in the form on plasminogen)

24
Q

give a summary of secondary haemostasis

A

fibrinogen released by the platelets to fibrin using thrombin (preactivated form called prothrombin)

25
how is plasminogen activated to plasmin?
- tissue plasminogen activator | - plasminogen binding to lysine residues on fibrin clot
26
what are the products of fibrin breakdown?
fibrin depredation products (FDP)
27
how does tranexamic acid (and antifibrolytic drug) work?
- derivative of lysine - competetive inhibitor of lysine so plasminogen can not bind to lysine - can not be activated to plasmin so reduced no of enzymes (plasmin) are produced to breakdown fibrin clot
28
what are the two different test of coagulation?
1) measuring the integrity of the extrinsic pathway (prothrombin time) 2) measuring the integrity of the extrinsic pathway (APTT)
29
What can cause an imbalance in haemostasis therefore a bleed?
1) Reduced platelet number/function (primary) 2) Reduction in coagulation factors (secondary) → VWF reduction = VW disease → Haemophilia A + B → Cause? Liver disease, anticoagulants, DIC (uncontrolled coagulation activation) 3) Incr. fibrinolysis → Cause? DIC, thrombolytic therapy
30
how is the risk increased for venous thrombosis?
1) Reduced no. of anticoagulants ie. antithrombin 2) reduced levels of fibrinolysis (e.g. in prganancy) 2) Incr. clotting factors/platelets (i.e. Factor VIII incr during preganancy, mutation, myeloproliferative disorders)
31
how is the risk increased for venous thrombosis?
1) Reduced no. of anticoagulants ie. antithrombin so more likely for coagulation to happen therefore more likely thrombosis 2) reduced levels of fibrinolysis (e.g. in prganancy) 2) Incr. clotting factors/platelets (i.e. Factor VIII incr during preganancy, mutation, myeloproliferative disorders)